Additional file 1 of Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)

Lim, Z. C.; Hoo, G. S.; Ang, J. H.; Teng, C. B.; Ang, L. W.; Lee, C. C.; Leo, Y. S.; Law, H. L.; Ng, O. T.; Wong, C. S.

doi:10.6084/m9.figshare.16916466.v1

12981_2021_402_MOESM1_ESM.docx (18.61 kB)

Additional file 1 of Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)

journal contribution

posted on 2021-11-02, 04:27 authored by Z. C. Lim, G. S. Hoo, J. H. Ang, C. B. Teng, L. W. Ang, C. C. Lee, Y. S. Leo, H. L. Law, O. T. Ng, C. S. Wong

Additional file 1: Table S1. Details of 4 individuals who failed the primary outcome for virological reasons. Table S2. Details of 21 individuals who failed the primary outcome for non-virological reasons. Table S3. Breakdown of All AEs. Table S4. Changes in eGFR stratificationA from baseline to end of follow up period (n=139)